No black box warning on record for Enjaymo
As of the latest FDA labeling reviewed, Enjaymo (SUTIMLIMAB-JOME) does not carry a black box warning. Standard warnings and precautions still apply — see the full Enjaymo medicine page for the complete safety profile.